Showing results (181-190 of 300) with videos related to
Sort By:
Pageof 30
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1987
The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjectsA H Thomson, H L Elliott, A W Kelman, et al.British Journal of Clinical Pharmacology|September 1, 1993
The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalaprilN J Macdonald, A Sioufi, C A Howie, et al.Clinical and Experimental Pharmacology & Physiology|May 20, 1998
Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular diseaseS J Cleland, J R Petrie, S Ueda, et al.Journal of Human Hypertension|September 1, 1987
Risk factor modification in hypertension--success and failureJ L Curzio, J L Reid, S Kennedy, et al.Clinical Pharmacology and Therapeutics|September 1, 1993
Pharmacodynamic modeling of the antihypertensive response to amlodipineR Donnelly, P A Meredith, S H Miller, et al.Clinical Pharmacokinetics|March 1, 1985
Clinical pharmacokinetics of prazosin--1985J Vincent, P A Meredith, J L Reid, et al.Clinical Pharmacology and Therapeutics|December 1, 1984
Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjectsF Pasanisi, H L Elliott, P A Meredith, et al.Journal of Cardiovascular Pharmacology|April 1, 1992
Combination of nifedipine and doxazosin in essential hypertensionR Donnelly, H L Elliott, P A Meredith, et al.British Journal of Clinical Pharmacology|May 1, 1984
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist propertiesH L Elliott, K McLean, P A Meredith, et al.Journal of Cardiovascular Pharmacology|August 1, 1990
Vascular pressor responses in treated and untreated essential hypertensionR Donnelly, H L Elliott, C A Howie, et al.Pageof 30